Gallium-68 DOTA-Zoledronate - Isotopen Technologien Munchen
Alternative Names: 68Ga-DOTA-ZoledronateLatest Information Update: 28 Aug 2022
At a glance
- Originator Johannes Gutenberg-University Mainz
- Developer Isotopen Technologien Munchens
- Class Bisphosphonates; Imaging agents; Imidazoles; Organometallic compounds; Radioisotopes; Radiopharmaceutical diagnostics; Small molecules
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bone metastases
Most Recent Events
- 28 Aug 2022 No recent reports of development identified for clinical-Phase-Unknown development in Bone metastases(Diagnosis) in Germany (Parenteral)
- 22 Jul 2019 Clinical trials in Bone metastases (Diagnosis) in Germany (Parenteral)
- 15 Mar 2019 Pharmacokinetics data from a clinical trial in Bone metastases (Diagnosis) released by Johannes Gutenberg-University Mainz